What is the recommended dose of colchicine (Colcrys) for an acute gout attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colchicine Dosing for Acute Gout Attack

For an acute gout attack, administer colchicine 1.2 mg (two tablets) at the first sign of the flare, followed by 0.6 mg (one tablet) one hour later, for a total of 1.8 mg over one hour, then continue 0.6 mg once or twice daily until the attack resolves. 1, 2, 3

Critical Timing Window

  • Treatment must be initiated within 36 hours of symptom onset to be effective; delaying beyond this window significantly reduces efficacy 1, 2
  • The "pill in the pocket" approach allows fully informed patients to self-medicate at the first warning symptoms, ideally within 12 hours of onset for maximum effectiveness 1

Continuation Dosing After Initial Treatment

  • After the loading doses (1.2 mg + 0.6 mg), wait 12 hours, then resume prophylactic dosing of 0.6 mg once or twice daily until the acute attack completely resolves, typically within a few days 1, 2, 3
  • If a gout flare occurs while already on prophylactic colchicine, you may administer the acute treatment regimen (1.2 mg followed by 0.6 mg one hour later), then wait 12 hours before resuming the prophylactic dose 3

Evidence Supporting Low-Dose Regimen

  • The AGREE trial demonstrated that this low-dose regimen (1.8 mg total) is equally effective as the older high-dose regimen (4.8 mg over 6 hours) for achieving 50% or greater pain reduction at 24 hours, with a number needed to treat of 5 1
  • Critically, the low-dose regimen causes significantly fewer gastrointestinal adverse events compared to high-dose colchicine 1, 4
  • The older regimen of 0.5 mg every 2 hours until relief or toxicity is obsolete and causes severe diarrhea in most patients 1

Absolute Contraindications

  • Do not use colchicine in patients taking strong CYP3A4 inhibitors (clarithromycin, erythromycin, ketoconazole) or P-glycoprotein inhibitors (cyclosporine) - this is an absolute contraindication 1, 2
  • Avoid in severe renal impairment (GFR <30 mL/min); if absolutely necessary, reduce to a single 0.6 mg dose with no repeat treatment for at least two weeks 1, 2
  • Patients with both renal or hepatic impairment AND taking potent CYP3A4 or P-glycoprotein inhibitors should not receive colchicine 1

Dose Adjustments for Drug Interactions

  • For moderate CYP3A4 or P-glycoprotein inhibitors, dose reduction is required 2, 3
  • Grapefruit juice can increase colchicine concentrations and should be avoided 5
  • Concomitant statin use may increase risk of myopathy 5

Common Pitfalls to Avoid

  • Never exceed 1.8 mg in the first hour - higher doses provide no additional benefit but substantially increase gastrointestinal toxicity 1, 3
  • The maximum recommended dose for treatment of a gout flare is 1.8 mg over one hour 3
  • Do not use colchicine as an analgesic for pain from other causes 3

Alternative Options if Colchicine Contraindicated

  • Use full FDA-approved doses of NSAIDs (naproxen, indomethacin, or sulindac) until the attack completely resolves 1
  • Oral corticosteroids (prednisone 30-35 mg/day for 3-5 days) are effective alternatives 1
  • For severe attacks involving multiple large joints, combination therapy with colchicine and NSAIDs provides synergistic anti-inflammatory effects 1

References

Guideline

Treatment of Acute Gout Flares

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colchicine Dosage for Acute Gout and Prophylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Colchicine for acute gout.

The Cochrane database of systematic reviews, 2021

Research

Colchicine poisoning: the dark side of an ancient drug.

Clinical toxicology (Philadelphia, Pa.), 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.